Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Adds Second 454 Sequencer for Plant Genome Jobs

NEW YORK (GenomeWeb News) – Keygene said today that it has added a second 454 GS FLX sequencer from Roche to its arsenal, and it has upgraded both sequencers to the higher-throughput Titanium systems for use in the company’s headquarters in the Netherlands.
 
The company said it will use its enhanced sequencing power to meet increasing demand for whole genome crop plant projects. The company also said it has made “new investments” in its bioinformatics infrastructure to handle large-scale data storage and analysis projects such as mining SNPs, mutant alleles, gene identification, and genome assembly.
 
Keygene will use identified SNPs for “cost effective genotyping and molecular breeding of field, vegetable, and flower crops,” the firm said.
 
Keygene’s VP of Business Development, Mark van Haaren, said in a statement that its past sequencing and informatics enhancements have allowed the company to “develop new applications such as a novel whole genome sequencing procedure of smaller to mid-sized plant genomes.” 
 
The company bought its first GS FLX in April 2007.
 
Financial terms of the agreement were not released.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.